Archive
Time to reconsider the ‘command and control’ strategy?
Can a price regulator react timeously to changes in the market and deliver true benefit to the people? In January this year, the Department of Health issued its annual notice on single exit price (SEP) adjustments for 2013, in which pharmaceutical manufacturers are allowed a maximum increase of 5.8% on
19 March 2013